These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 32645686

  • 1. Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy.
    Ferasin L, Kilkenny E, Ferasin H.
    J Vet Cardiol; 2020 Aug; 30():23-31. PubMed ID: 32645686
    [Abstract] [Full Text] [Related]

  • 2. Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy.
    Seo J, Payne JR, Novo Matos J, Fong WW, Connolly DJ, Luis Fuentes V.
    J Vet Intern Med; 2020 Sep; 34(5):1718-1727. PubMed ID: 32822105
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Mitral valve dysplasia in a cat causing reversible left ventricular hypertrophy and dynamic outflow tract obstruction].
    Kuijpers NW, Szatmári V.
    Tijdschr Diergeneeskd; 2011 May 01; 136(5):326-31. PubMed ID: 21614848
    [Abstract] [Full Text] [Related]

  • 9. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P, Uziebło-Życzkowska B, Gielerak G, Stańczyk A, Piotrowicz K, Piechota W, Smurzyński P, Skrobowski A.
    Adv Clin Exp Med; 2017 May 01; 26(2):295-301. PubMed ID: 28791849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biologic variability in NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral valve degeneration.
    Ruaux C, Scollan K, Suchodolski JS, Steiner JM, Sisson DD.
    Vet Clin Pathol; 2015 Sep 01; 44(3):420-30. PubMed ID: 26108974
    [Abstract] [Full Text] [Related]

  • 12. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR, Choi JO, Han HJ, Chang SA, Park SJ, Lee SC, Choe YH, Park SW, Oh JK.
    Int J Cardiovasc Imaging; 2012 Apr 01; 28(4):763-72. PubMed ID: 21516440
    [Abstract] [Full Text] [Related]

  • 13. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease.
    Ogawa M, Hori Y, Kanno N, Iwasa N, Toyofuku T, Isayama N, Yoshikawa A, Akabane R, Sakatani A, Miyakawa H, Hsu HH, Miyagawa Y, Takemura N.
    J Vet Med Sci; 2021 Apr 24; 83(4):705-715. PubMed ID: 33551383
    [Abstract] [Full Text] [Related]

  • 14. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF.
    J Vet Cardiol; 2009 May 24; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [Abstract] [Full Text] [Related]

  • 15. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
    Fox PR, Rush JE, Reynolds CA, Defrancesco TC, Keene BW, Atkins CE, Gordon SG, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Macdonald KA, Lehmkuhl LB, Nguyenba TP, Sydney Moise N, Lefbom BK, Hogan DF, Oyama MA.
    J Vet Intern Med; 2011 May 24; 25(5):1010-6. PubMed ID: 21985136
    [Abstract] [Full Text] [Related]

  • 16. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
    Neeland IJ, Drazner MH, Berry JD, Ayers CR, deFilippi C, Seliger SL, Nambi V, McGuire DK, Omland T, de Lemos JA.
    J Am Coll Cardiol; 2013 Jan 15; 61(2):187-95. PubMed ID: 23219305
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The diagnostic significance of the plasma N-terminal pro-B-type natriuretic Peptide concentration in asymptomatic cats with cardiac enlargement.
    Tominaga Y, Miyagawa Y, Toda N, Takemura N.
    J Vet Med Sci; 2011 Aug 15; 73(8):971-5. PubMed ID: 21467762
    [Abstract] [Full Text] [Related]

  • 20. Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly.
    Eggers KM, Lindahl B, Venge P, Lind L.
    Int J Cardiol; 2018 Apr 15; 257():300-305. PubMed ID: 29506712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.